Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study's aim is to evaluate the feasibility of introducing a women's malignancy survivorship clinic incorporating symptom management through ePRO collection (complex intervention) into routine follow up care in patients with early-stage Hormone Receptor(HR)-positive breast and gynaecologic cancer post primary curative therapy.
Full description
Study Design: Complex interventional study. Specific Aims: To evaluate the feasibility of introducing a women's malignancy survivorship clinic in Ireland incorporating symptom management through electronic Patient Reported Outcomes (ePROs) collection (complex intervention) into routine follow-up care in patients with early-stage HR-positive breast and gynecologic cancer post-primary therapy.
Sampling Method: Randomized Control Design (Parallel Arms). Sample Size: 200.
Entry Criteria: Women with early-stage breast/gynecologic cancer within 12 months of completion of primary curative therapy:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Women aged > or = 18 years.
Ability to read and understand English.
Access to internet.
Early-stage breast/gynaecologic cancer within 12 months of completion of primary curative therapy:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal